Italia markets closed

BMY Aug 2024 62.500 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,13000,0000 (0,00%)
Alla chiusura: 12:30PM EDT
Schermo intero
Chiusura precedente0,1300
Aperto0,1300
Denaro0,0200
Lettera0,0500
Prezzo d'esercizio62,50
Scadenza2024-08-16
Min-Max giorno0,1300 - 0,1300
Contratto - Min-MaxN/D
Volume1
Open Interest167
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri